Both in Pharmaceuticals
Insmed vs Viatris
Over the past year INSM returned −43.9% and VTRS returned +79.7%; their daily moves had a correlation of -0.14.
INSM −43.9% VTRS +79.7%Growth of $1, one year, split-adjusted
| Metric | INSM | VTRS |
|---|---|---|
| Price | $104.44 | $18.92 |
| Market cap | $22.91B | $21.73B |
| Today | −4.46% | +1.34% |
| 1 month | +0.6% | +7.4% |
| 6 months | −25.1% | +21.9% |
| Year to date | −40.0% | +52.0% |
| 1 year | −44.9% | +82.6% |
| Revenue growth (YoY) | +268.4% | +4.9% |
| Gross margin | 85.1% | 38.8% |
| Net margin | −19.1% | −3.2% |
| P/E (TTM) | — | — |
| Price / sales | 15.1× | 1.5× |
| Net cash | $569.9M | -$12.46B |
| Dividend yield | — | 2.54% |
| Volatility (60d) | 47.3% | 23.2% |
| Short % of float | 6.3% | 3.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).